1. Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas. Issue 5 (20th August 2021) Authors: Welling, D. Bradley; Collier, Katharine A.; Burns, Sarah S.; Oblinger, Janet L.; Shu, Edina; Miles‐Markley, Beth A.; Hofmeister, Craig C.; Makary, Mina S.; Slone, H. Wayne; Blakeley, Jaishri O.; Mansouri, S. Alireza; Neff, Brian A.; Jackler, Robert K.; Mortazavi, Amir; Chang, Long‐Sheng Journal: Laryngoscope investigative otolaryngology Issue: Volume 6:Issue 5(2021) Page Start: 1008 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗